Associated Papers
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
Han RC et al.
Expert Opinion on Orphan Drugs, 2021
Genetic defects of CHM and visual acuity outcome in 24 choroideremia patients from 16 Japanese families.
Hayashi T et al.
Scientific Reports, 2020
Multimodal assessment of choroideremia patients defines pre-treatment characteristics.
Seitz IP et al.
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie, 2015
Select a paper to view details